ask="0.9600"
ask_size="900"
average_daily_volume="1391160"
bid="0.8920"
bid_size="1400"
book_value="0.6060"
change="-0.0311"
change_from_200_day_moving_average="-1.7946"
change_from_50_day_moving_average="-0.0286"
change_from_52_week_high="-4.0100"
change_From_52_week_low="0.4199"
change_in_percent="-3.2702%"
close="0.9199"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.2370"
ebitda="-8.78M"
eps_estimate_current_year="-1.1200"
eps_estimate_next_quarter="-0.2500"
eps_estimate_next_year="0.1900"
ex_dividend_date="N/A"
float_shares="7029000"
high="0.9900"
high_52_weeks="4.9299"
last_trade_date="1/18/2017"
last_trade_price="0.9199"
last_trade_size="100"
last_trade_time="3:59pm"
low="0.9100"
low_52_weeks="0.5000"
market_capitalization="6.57M"
moving_average_200_day="2.7145"
moving_average_50_day="0.9485"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.3300"
open="0.9900"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-66.1115%"
percent_change_from_50_day_moving_average="-3.0138%"
percent_change_from_52_week_high="-81.3404%"
percent_change_from_52_week_low="+83.9800%"
previous_close="0.9510"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="4.8416"
price_per_book="1.5693"
price_per_sales="2.6566"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.5800"
stock_exchange="NCM"
symbol="OPXA"
volume="544006"
weeks_range_52="0.5000 - 4.9299"
